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Abstract:
Background: Panton Valentine Leukocidin
(PVL) toxin, responsible for increased
virulence and more severe infections can be
found in both Methicillin-sensitive and
Methicillin-resistant strains of Staphylococcus
aureus  (MSSA and MRSA). Aims &
Objectives:  To generate baseline data on the
extent of MRSA infections and to estimate the
frequency of PVL-positive S.aureus in
Belgaum, South India. Material & Methods: 70
clinical isolates of S.aureus were obtained from
various laboratories in Belgaum city. These
isolates were identified, phenotypically
characterized as MRSA/MSSA by disc diffusion
method using oxacillin discs (1 µg) and
genetically by multiplex PCR for mecA and fem
B genes. PCR was subsequently carried out on
all isolates to detect LukS-PV and LukF-PV
genes, the markers for potential producers of
PVL toxin. Results: 27 out of 70 isolates
(38.6%) were confirmed as MRSA by PCR for
mecA. The prevalence of PVL gene was 85.1%
and 48.8% in MRSA and MSSA respectively.
The overall prevalence of PVL positive S.aureus
was 62.85%. Conclusion:  Our study showed
high percentage of PVL positive MRSA and
MSSA, higher than the most reports
worldwide.  In the backdrop of bacterial strains
gaining multiple drug resistance, our study
warrants further epidemiological studies in
hospitals and community levels in the region.
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Introduction:
Staphylococcus aureus, frequently a member
of the normal skin flora and nasal cavity often
causes abscesses, infections of wound, skin,
soft tissue, osteomyelitis, endocarditis,
pneumonia etc. It may also cause staphylococcal
scalded skin syndrome, a severe disease in
infants or the toxic shock syndrome.
Methicillin resistant S. aureus (MRSA) is one
of a member of greatly feared strains of S.
aureus which have become resistant to many
antibiotics. MRSA strains have been associated
with nosocomial or hospital acquired infections
(HA-MRSA infections) world over and have
emerged as an important cause of community
acquired infections (CA-MRSA) as well [1].
Resistance to methicillin is mostly determined
by the presence of mecA gene encoding altered
penicillin binding protein which shows low
affinity to b-lactam antibiotics [2].
The pathogenicity of S. aureus infections is
related to various bacterial surface components
(e.g. capsular polysaccharide and protein A),
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including those recognizing adhesive matrix
molecules (e.g. clumping factor and fibronectin
binding protein) and to extracellular enzymes
and toxins (e.g. coagulase, staphylokinase,
hyaluronidase haemolysins, enterotoxins, toxic
shock syndrome toxin, exfoliatins and Panton
Valentine Leukocidin or PVL etc.) [3].
PVL is one of the most important and
extensively investigated proteins that belongs
to the recently described family of
synergohymenotropic toxins [4]. These toxins
damage membranes of host defense cells by
synergistic action of two non-associated
classes of secretory proteins designated as
Luk-S and Luk-F, which are encoded by two
contiguous and co-transcribed genes viz.,
LukF-PV and LukS-PV [5] of  bacteriophages
inserted in the bacterial chromosome. PVL is
leukotoxic by pore induction for human
polymorphonuclear cells and macrophages [6].
Epidemiological and clinical data [7] provide
compelling evidence that the high virulence
potential of community acquired MRSA is
associated with genes like lukF-PV and
lukS-PV (PVL), but direct evidence that PVL
plays a role in pathogenesis has been limited
[8]. The presence of PVL in S. aureus appears
to be associated with increased disease
severity, ranging from cutaneous infection
requiring surgical drainage to severe chronic
osteomyelitis, and severe necrotizing
pneumonia which could be fatal [9]. PVL
production has been linked with furuncles,
cutaneous abscess and severe necrotic skin
infections in school children [10] and in
certain communities [11]. The PVL toxin
being an important virulence factor led us to
investigate the frequency of PVL producing
S.aureus in Belgaum in Northwest Karnataka,
(India) which has several tertiary care
hospitals & caters to a large number of patients
from North Karnataka, Southern Maharashtra
and Goa. Indoor as well as outdoor patients were
included together in the study with the
intention to cover cases of both community
acquired as well as hospital acquired infections
for obtaining a more generalized picture.
Material and Methods:
Samples:
A total of 70 isolates of S. aureus were
obtained from microbiology laboratory of a
tertiary care centre in Belgaum that receives
samples from various diagnostic laboratories,
primary and secondary care centres as well as
outdoor and indoor patient departments (OPD
and IPD) of attached hospitals.
Identification:
Samples identified as S.aureus by standard
microbiological methods at microbiology
departments of respective hospitals were
collected and reconfirmed as S.aureus at
Regional Medical Research Centre (ICMR),
Belgaum by conventional biochemical tests
using standard protocols followed by
identification of a few representative strains by
Vitek 2 Compact automated microbial
identification system using Gram positive (GP)
cards (Bio Merieux, USA).
MRSA and MSSA assays and
antimicrobial sensitivity tests:
All isolates were subjected  to phenotypic
antimicrobial susceptibility  tests by Kirby
Bauer disc diffusion method using Oxacillin
discs, 1µg (Hi-Media, India) following CLSI
guidelines [14]. The zone of inhibition was
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determined after 24 h of incubation at 35°C
(susceptible >13 mm; intermediate 11-12 mm;
and resistant <10 mm). Standard MRSA strain
(ATCC43300) and MSSA strain (ATCC25923)
were included in each batch. A few random
strains were subjected to automated antibiotic
sensitivity testing by Vitek 2 Compact system
(Bio Merieux, USA) as well, for confirmation.
DNA extraction for PCR:
Bacterial DNA was extracted from overnight
cultures of S.aureus by CTAB-NaCl method
[15]. The quality and quantity of isolated DNA
was determined using Nanodrop 1000
spectrophotometer (JH BioSciences, USA) at
260/280 nm as well as visually by horizontal
gel electrophoresis in 1% agarose.
Multiplex PCR for detection of mecA
and fem B genes:
Multiplex PCR for the detection of mecA and
femB genes was carried out following Unal et
al., 1995 [16].  1µl of 60 ng of the extracted
DNA was added to 24 µl of PCR amplification
mix consisting of 16 µl of doubled distilled
autoclaved water, 2.5 µl of 10X Taq buffer (Tris
with 15 mM MgCl2), 1µl of 2.5mM dNTP mix
(Merck, India), 0.5 µl of 3U Taq polymerase
(Merck, India), and 0.5mM of each primer. The
details of primers (Sigma, India) used for the
detection of mecA and femB gene are given in
Table 1. Amplifications were carried out using
thermal cycler (iCycler, BioRad Inc., USA)
with PCR conditions that consisted of 30 cycles
of denaturation at 94°C for 45 s, annealing at
50°C for 45 s and extension at 72°C for 1 min
with a final extension at 72C for 2 min. The
PCR products were subjected to agarose gel
electrophoresis using gel red dye and images
were acquired using Alpha Imager gel
documentation system (JH biosciences, USA).
PCR for detection of luk-F (PV) and
luk-S (PV) genes:
1 µl containing 60 ng of extracted S.aureus
DNA was added to 24 µl of PCR amplification
mix consisting of 18 µl of doubled distilled
autoclaved water, 2.5 µl of 10X Taq buffer (Tris
with 15 mM MgCl2), 1µl of 2.5 mM dNTP mix
(Merck, India), 0.5 µl of 3U Taq polymerase
(Merck, India) and 0.5 mM of each primer
(Table 1). Amplifications were carried out
using thermal cycler (iCycler, BioRad Inc.,
GTA GAA ATG ACT GAA CGT CCG ATA A
GTA GAA ATG ACT GAA CGT CCG ATA A
TTA CAG AGT TAA CTG TTA CC
ATA CAA ATC CAG CAC GCT CT
ATC ATT AGG TAA AAT GTC TGG ACA TGA TCC A
GCA TCA AGT GTA TTG GAT AGC AAA AGC
Table 1: Details of oligonucleotide primers used in PCR.
Primer Target gene Sequence (5-3) Amplicon size Ref.
Mec A1
Mec A2
Fem B1
Fem B2
Luk-PV-1
Luk-PV-2
mecA
femB
Luk-S(PV)
& luk-F(PV)
310 bp
651bp
433bp
Jonas et al.
1999 [33]
Jonas et al.
1999 [33]
Lina et al.
1999 [27]
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USA) with PCR conditions that consisted of
initial denaturation at 94°C for 99 min followed
by 10 cycles of denaturation at 94°C for 60 s,
annealing at 55°C for 60 s. and extension at
72°C for 90 s. followed by 25 cycles of
denaturation at 94°C for 60 s, annealing at 50°C
for 60 s and extension at 72°C for 90 s, with
final extension at 72°C for 5 min. The PCR
products were electrophoresed in 1% agarose
gels and documented.
Results:
Out of the 70 isolates of S. aureus, 31 were
found to be resistant to Oxacillin (1 µg) by
Kirby Bauer disc diffusion method (Table 2)
while 30 were sensitive and 9 were classified
as having intermediate resistance (inhibition
zone size between 11 to 12 mm) as per CLSI
guidelines.
The mecA gene, considered as a genotypic
marker for MRSA was detected by PCR in 27
isolates that included 20 Oxacillin (1 µg)
resistant strains, 2 strains that showed
Table 2: Results of Oxacillin susceptibility test
in disc diffusion and mecA gene PCR for differ-
entiation of MRSA from MSSA (n=70).
Total
PCR (mecA)
+ ve - ve
Resistant
Intermediate
Sensitive
TOTAL
O
x
a
c
i
l
l
i
n
(
1
 
µ
g
)
20
2
5
27
11
7
25
43
31
9
30
70
intermediate resistance and 5 strains that were
sensitive to Oxacillin (Table 2).
Among the 70 isolates, 19 (27.14 %) did not
possess the femB marker out of which 6
(22.22%) were mecA positive (MRSA) and 13
(30.23%) were mecA negative (MSSA).
PCR for the PVL marker lukS- lukF-PV
revealed that 23 out of 27 MRSA (mecA
positive) isolates harbored this gene (85.1%)
while it was 21 out of 43 (48.8%) in MSSA
(mecA negative). Overall PVL positivity was
62.85 % (Table 3).
Table 3:  PCR results for LukPV (PVL) positivity among MRSA and MSSA (n=70).
MRSA (mecA +ve) MSSA (mecA ve)
femB +ve femB ve
PVL
positivity femB +ve femB ve
PVL
positivity
LukPV (PVL)  +ve
LukPV (PVL)   ve
Total
19
2
21
4
2
6
23/27
(85.1%)
19
11
30
2
11
13
21/43
(48.8%)
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Fig. 1: Agarose gel showing amplification of
mecA and femB in multiplex PCR. Lane1:  MSSA
(ATCC25923); Lane2: MRSA (ATCC43300);
Lanes 3 to 12: Clinical isolates; Lane13: 100bp
DNA ladder.
Figure 2: Agarose gel showing amplification of
LukF-PV, lukS-PV. Lane 1: PVL negative
S.aureus (control); Lane 2: PVL positive S.aureus
(reference strain). Lanes 3 to 13: Clinical iso-
lates. Lane14: 100bp DNA ladder.
Discussion:
Infections due to S.aureus are very common
and MRSA continues to be a serious and
formidable challenge to health care providers
as their prevalence is reported to be increasing
exponentially [17]. In the past, MRSA
infections were reported mostly from
hospitalized patients but now they are
encountered in community settings as well.
Understanding the types of S. aureus
infections, their pattern and distribution, as well
as the factors associated with their spread are
of paramount importance for its management
and control.
Conventional phenotypic method of
identification of MRSA by Oxacillin discs was
compared with the PCR based molecular
method based on detection of the presence of
mecA  gene, considered predominant
molecular marker for MRSA, although there are
other rarer non-mecA mediated mechanisms of
developing Methicillin resistance [18,19].
Objectivity of PCR helped to ascertain the
affiliations of 9 isolates that showed interme-
diate resistance to Oxacillin out of which 2 iso-
lates were adjudged MRSA because of possess-
ing mecA gene and 7 isolates as MSSA due to
absence of this marker. PCR for mecA there-
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fore was found to be more useful in determi-
nation of MRSA and MSSA status of S. aureus
isolates. Among the 7 mecA negative isolates
showing intermediate resistance to Oxacillin,
the possibility of a few strains having non-mecA
mediated Methicillin resistance cannot be ruled
out. The 11 isolates which were mecA negative
but Oxacillin resistant were due to the absence
of mecA gene but its phenotypic expression was
most likely due to non-mecA mediated Methi-
cillin resistance as described earlier [20].
In our study, 27 of the 70 isolates (38.6%) were
found to be MRSA by mecA positivity in PCR.
The prevalence of colonization or infection by
MRSA continues to increase [21] with consid-
erable variation between countries [22] or hos-
pitals in the same area [23]. MRSA infections
in India have been recorded between 18.4 and
33.3% among hospitalized patients [24] in gen-
eral while is stated to be an under reported en-
tity in community settings [25]. In our study,
overall 38.6 % mecA positivity, although not
the highest reported from the country, can still
be considered on the higher side in this region
and is therefore a cause for concern.
Kobayashi et al. (1994) reported that though
femB genes are detectable only in S. aureus,
an absence of femB gene does not mean that
the isolate is not S. aureus. They showed up to
3% of S. aureus isolates in their study were
negative for femB. In our study, we found 19
femB negative isolates (27%) out of which, 6
were mecA positive (MRSA), and among the
remaining 13 mecA negative (MSSA), 2 were
PVL positive. Therefore 8 isolates, despite be-
ing femB negative, were either positive for mecA
or PVL. Eleven isolates were negative for femB,
mecA and PVL despite being reconfirmed as
S.aureus phenotypically. We therefore con-
clude that femB negative S.aureus may be
present in much higher numbers in clinical
specimens than previously reported. In agree-
ment with the studies of Kobayashi et al. (1994)
[26], we observed that femB negativity was more
in MSSA (30.23 %) than in MRSA (22.22 %).
In our study we found 85.1% MRSA isolates
were positive for PVL gene while it was 48.8%
in MSSA. The high percentage of PVL produc-
ing MRSA as well as MSSA strains is interest-
ing and can be due to the carriage of large parts
of SCC mec including the luk-F and luk-S genes
to other resistant strains of S.aureus by vari-
ous ways of recombination. However nearly half
of MSSA (48.8%) strains producing PVL gene
is also a cause for concern.  According to some
reports, the prevalence of PVL positive S.
aureus is less than 5% in France, 4.9% in UK,
8.1% in Saudi Arabia, 14.3% in Bangladesh and
35% in Cape Verde Islands [27-31]. From In-
dia, DSouza et al. (2010) reported 64% PVL
positive MRSA from Mumbai [32], which is
quite high, compared to other countries and in
our study 62.85% PVL positive S.aureus was
seen. The high prevalence of PVL may also be
due to misuse of antibiotics in the country caus-
ing selective pressure for development of re-
sistant strains along with the virulence factor
i.e. PVL.
The 62.85% PVL positive S.aureus isolates
found in our study is much higher than most
reports worldwide. In the backdrop of bacte-
rial strains gaining resistance to wide spectrum
of antibiotics recently, the high incidence of
MRSA coupled with relatively higher propor-
tions of potential PVL producers, both in MRSA
and MSSA, warrants setting up a surveillance
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mechanism for S.aureus infections at hospital
and community levels in the region. Our find-
ings also underscore the need for genetic stud-
ies on S.aureus infections in India and other
parts of the world as well.
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